Developemental Research Program

$121,796P50FY2009CANIH

Mayo Clinic Rochester, Rochester MN

Investigators

Linked publications & trials

Paper 31685261 Paper 28936267 Paper 27575027 Paper 26432404 Paper 25762434 Paper 25463993 Paper 25304993 Paper 25186418 Paper 25132238 Paper 25074478 Paper 24998118 Paper 24674886 Paper 24619754 Paper 24491799 Paper 24480624 Paper 24349376 Paper 24200954 Paper 23863692 Paper 23826159 Paper 23770138 Paper 23475919 Paper 23402817 Paper 23387773 Paper 23258495 Paper 23181221 Paper 23149913 Paper 23037808 Paper 22972493 Paper 22866026 Paper 22694073 Paper 22677074 Paper 22610453 Paper 22581054 Paper 22456196 Paper 22423235 Paper 22386179 Paper 22308105 Paper 22247499 Paper 22235324 Paper 21948470 Paper 21806544 Paper 21778211 Paper 21693399 Paper 21692049 Paper 21630295 Paper 21630294 Paper 21629218 Paper 21615849 Paper 21508312 Paper 21436259 Paper 21419439 Paper 21377181 Paper 21324924 Paper 21251688 Paper 21238503 Paper 21178268 Paper 21166500 Paper 21159607 Paper 21151630 Paper 21084477 Paper 20956380 Paper 20861008 Paper 20647745 Paper 20595086 Paper 20465393 Paper 20428214 Paper 20407210 Paper 20404550 Paper 20404532 Paper 20335092 Paper 20331369 Paper 20329821 Paper 20228873 Paper 20166126 Paper 20153805 Paper 20113864 Paper 20065091 Paper 20042563 Paper 19996289 Paper 19964365 Paper 19962666 Paper 19959199 Paper 19934328 Paper 19920152 Paper 19902470 Paper 19789348 Paper 19773744 Paper 19765790 Paper 19755961 Paper 19676081 Paper 19638584 Paper 19623543 Paper 19517021 Paper 19469693 Paper 19345321 Paper 19276267 Paper 19229700 Paper 19164447 Paper 19160488 Paper 19064571

Abstract

The Developmental Research Program is designed to develop innovative prostate cancer translational research. As such, it supports novel translational research projects or research projects with definite potential to provide a scientific base for future translational research. This program is of great importance to the success of the Prostate SPORE because it enables a proactive stance in identifying and supporting innovative hypothesis-driven research. The availability of this support also provides a stimulus for creativity in the research community, a vehicle for encouraging the interaction of basic scientists and translational investigators, and an opportunity for expanding the research spectrum of the SPORE by pursuing new leads based on discoveries and/or opportunities that arise. We have requested $100,000 in the application to support this program. In addition Mayo will provide an additional $50,000 for the Developmental Research Program (See letter of commitment from Dr. Hugh Smith, CEO and Chair of the Board of Governors of Mayo Clinic, Rochester, and Vice President of the Mayo Foundation). Thus, we plan to commit a total of $150,000 to the Developmental Research Program.

View original record on NIH RePORTER →